000 01702nam##2200277za#4500
0019.647224
003CaOODSP
00520200330140426
007ta
008150407|1998||||xxc|||||     f|0| 0 eng|d
020 |a0-662-27482-2
040 |aCaOODSP|beng
043 |an-cn---
0861 |aRG79-4/1-1998E
1101 |aCanada. |bPatented Medicine Prices Review Board.
24510|aRoad map for the next decade : |breport on the PMPRB's public consultations
260 |aOttawa - Ontario : |bPatented Medicine Prices Review Board |c1998.
300 |a34p. in various pagings. : |bgraphs, tables ; |c28 cm.
500 |aContents: Message from the Board.--Context.--What stakeholders are saying about Canada's pharmaceutical policy and the PMPRB's mandate.--What stakeholders are saying about how the Board carries out its mandate.--Action plan for follow-up on issues raised by stakeholders.--Conclusion.--Appendices. Accompanied by: Highlights.--Consultation policy.--PMPRB research agenda: 1998-2000.--PMPRB Study series S-9811: Trends in patented veterinary medicine prices. drug prices.--U.S. prices: preliminary outline of issues.--Notice and comment: regulating patented veterinary medicine prices. Department of Veterans Affairs formulary.--Price review process: preliminary outline of issues.--Category 3 drug prices: preliminary outline of issues.--Notice and comment: regulating patented veterinary medicine prices.
563 |aSoftcover
590 |a99-01|b1999-01-08
69007|aDrugs|2gcpds
69007|aPatents|2gcpds
69007|aPrices|2gcpds
77508|tLe guide pour la prochaine décennie : |w(CaOODSP)9.680649
7760#|tRoad map for the next decade : |w(CaOODSP)9.698387